These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4281242)

  • 21. The status of measles after five years of mass vaccination in the USSR.
    Burgasov PN; Andzaparidze OG; Popov VF
    Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age of measles immunization in tropics.
    Mirchamsy H; Shafyi A; Mahinpour M; Nazari P
    Dev Biol Stand; 1978; 41():191-4. PubMed ID: 572788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On vaccination against measles with live and attenuated virus (Schwarz strain)].
    Monaci V; Imperato C; Battistini A; Nardi G; Grzincich GL; Bellelli E; Mazzeo G
    Ann Sclavo; 1973; 15(3):134-40. PubMed ID: 4776383
    [No Abstract]   [Full Text] [Related]  

  • 24. Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial.
    Swartz TA; Klingberg W; Klingberg MA
    Infection; 1974; 2(3):115-7. PubMed ID: 4606362
    [No Abstract]   [Full Text] [Related]  

  • 25. [Humoral immunity indices of measles in reinoculated schoolchildren].
    Miroshnikova NK; Smorodinova IP; Smorodintsev AA; Petrova VN
    Tr Inst Im Pastera; 1983; 61():145-51. PubMed ID: 6235627
    [No Abstract]   [Full Text] [Related]  

  • 26. [Development of measles vaccination in Austria].
    Huber EG; Rannon L
    Padiatr Padol; 1973; 8(3):247-56. PubMed ID: 4715034
    [No Abstract]   [Full Text] [Related]  

  • 27. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.
    Dai B; Chen ZH; Liu QC; Wu T; Guo CY; Wang XZ; Fang HH; Xiang YZ
    Bull World Health Organ; 1991; 69(4):415-23. PubMed ID: 1934235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 29. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 30. Subcutaneous and intranasal administration of RA 27-3 rubella vaccine. Alone and in conjunction with live attenuated measles vaccine.
    Saidi S; Naficy K
    Am J Dis Child; 1969 Aug; 118(2):209-12. PubMed ID: 5794816
    [No Abstract]   [Full Text] [Related]  

  • 31. Epidemiologic assessment of a nationwide multiple antigen vaccine campaign.
    Landrigan PJ; Rivas EN; Eddins DL
    J Trop Pediatr Environ Child Health; 1974 Jun; 20(3):135-40. PubMed ID: 4497571
    [No Abstract]   [Full Text] [Related]  

  • 32. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Field evaluation of combined more attenuated live measles (Moraten)-smallpox vaccine in Honduras and Costa Rica.
    Villarejos VM; Rodríguez-Aragonés A; Gúnera N; Arguedas JA; Buynak EB; Hilleman MR
    Am J Epidemiol; 1971 May; 93(5):384-91. PubMed ID: 5556398
    [No Abstract]   [Full Text] [Related]  

  • 34. [Revaccination of children inoculated against measles].
    Bolotovskiĭ VM; Titova NS; Bakhur EA; Tamm OM; Miartin IaK
    Pediatriia; 1981 Dec; (12):46-8. PubMed ID: 7335425
    [No Abstract]   [Full Text] [Related]  

  • 35. [The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years].
    Grigor'eva EP; Desheva IuA; Donina SA; Naĭkhin AN; Rekstin AR; Barantseva IB; Zavitkova EA; Moskvicheva TM; Zhavoronkov VG; Rudenko LG
    Vopr Virusol; 2002; 47(4):24-7. PubMed ID: 12271721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous administration of live attenuated measles vaccine with DTP vaccine.
    McBean AM; Gateff C; Manclark CR; Foster SO
    Pediatrics; 1978 Sep; 62(3):288-93. PubMed ID: 704197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles immunization: new recommendation.
    Krugman S
    JAMA; 1977 Jan; 237(4):366. PubMed ID: 576171
    [No Abstract]   [Full Text] [Related]  

  • 38. Measles IgM response during reinfection of previously vaccinated children.
    Linnemann CC; Hegg ME; Rotte TC; Phair JP; Schiff GM
    J Pediatr; 1973 May; 82(5):798-801. PubMed ID: 4698953
    [No Abstract]   [Full Text] [Related]  

  • 39. [Safety and immunogenicity of measles attenuated live vaccine prepared by master seed lot vaccine of Shanghai-191 strain].
    Zhang SJ; Xiao QY; Li FJ
    Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):423-5. PubMed ID: 20084967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of measles antibody after immunization.
    Domorázková E; Drevo M
    J Biol Stand; 1975; 3(2):225-30. PubMed ID: 1126966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.